Rat IgG2b kappa, Isotype Control
Based on 1 publication(s) in Google Scholar
Rat IgG2b kappa, Isotype Control is a rat IgG2b κ antibody isotype control. Rat IgG2b kappa, Isotype Control can be used as a negative control to exclude or reduce false positive results caused by nonspecific binding.
For research use only. We do not sell to patients.
- Purity: 99.69%
- Molecular Weight:146.54 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Rat IgG2b kappa, Isotype Control
More-
In Vivo Efficacy Study
-
Flow Cytometry
Biological Activity
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c mice with MDA-MB-231 cells[1]
-
Dosage:100 μg
-
Administration:i.p.; every three days for 28 days
-
Result:Did not inhibit tumor growth.
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Product Image
ELISA, FACS, Functional assay
Chemical Information
-
Appearance Liquid
-
Molecular Weight 146.54 kDa
-
Color Colorless to light yellow
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
NPJ Precis Oncol
Pan cancer research reveals the role of PTGDS in tumor suppression and immune regulation. [Abstract]2025 Sep 30;9(1):319. PMID: 41028158
Rat IgG2b kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: NPJ Precis Oncol. 2025 Sep 30;9(1):319. [Abstract]
The stable cell line was inoculated into immunocompetent BALB/c mice to generate subcutaneous xenografts, which were treated with either αPD‑L1 Ab (Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2), 100 μg; i.p.; every three days; HY-P99145) or IgG isotype control (Rat IgG2b kappa, Isotype Control (100 μg; i.p.; every three days)). Images of subcutaneous xenograft tumors harvested from euthanized mice in different groups.
Rat IgG2b kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: NPJ Precis Oncol. 2025 Sep 30;9(1):319. [Abstract]
The stable cell line was inoculated into immunocompetent BALB/c mice to generate subcutaneous xenografts, which were treated with either αPD‑L1 Ab (Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2), 100 μg; i.p.; every three days; HY-P99145) or IgG isotype control (Rat IgG2b kappa, Isotype Control (100 μg; i.p.; every three days)). Flow cytometric analysis of CD3+ cells within CD45+ cells and CD8+ cells within CD3+ T cells in the tumors.
Purity & Documentation
-
Data Sheet (259 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)